India's Highest ROCE Large Caps 2026: FMCG & IT Leaders

By DocStoX Research · Updated 1 July 2026 · 3 min read

Return on Capital Employed (ROCE) is one of the most reliable indicators of business quality — it tells you how much operating profit a company generates per rupee of capital deployed. A ROCE consistently above 25–30% typically signals a durable competitive advantage. In India's large-cap universe, a handful of FMCG and IT companies tower above the rest. Here's where they stand as of FY26, based on DocStoX data sourced from audited NSE/BSE filings.

What Is ROCE and Why Does It Matter?

ROCE = EBIT ÷ Capital Employed (Equity + Debt). Unlike ROE, ROCE is not inflated by financial leverage — a company with zero debt and a 50% ROCE is genuinely more efficient than one with high borrowings and a similar ROE. For long-term investors, ROCE above 20% sustained over multiple years is often a hallmark of a quality compounder.

Top Large Caps by ROCE — FY26 Data

The following table ranks large-cap stocks with ROCE above 25%, sourced from DocStoX data (NSE/BSE audited filings basis). All figures are from the latest available annual period.

Colgate-Palmolive India: ROCE of 105% — The Outlier

Colgate-Palmolive (India) Ltd (NSE: COLPAL) leads India's large-cap ROCE ranking with 105% — a figure that reflects a near-zero-debt balance sheet (D/E: 0.03) and strong pricing power in the oral care segment. PAT stands at ₹1,437 crore on revenues of ₹6,040 crore, giving a PAT margin of ~23.8%. The stock trades at 39x earnings with a market cap of ₹56,115 crore. The high ROCE is partly structural: Colgate's business requires minimal fixed capital, and its working capital cycle benefits from strong distributor collections.

Nestle India: 96% ROCE, Premium Valuations

Nestle India (NSE: NESTLEIND) follows with 96% ROCE and ROE of 67.85% — testament to its asset-light distribution model and dominant brands (Maggi, KitKat, Nescafe). Revenue reached ₹20,202 crore with PAT of ₹3,314 crore. The stock commands a significant valuation premium at 85x earnings (P/E: 85.12) and P/B of 52.5x, reflecting the market's confidence in consistent compounding. Debt is minimal (D/E: 0.08).

TCS: The IT ROCE Champion at 63%

Tata Consultancy Services (NSE: TCS) delivers a 63% ROCE with ROE of 51.8% — exceptional for India's largest IT company. Revenue stands at ₹2,67,021 crore and PAT at ₹49,454 crore, with an EBITDA margin of 27% and PAT margin of 18.5%. D/E is 0.11, effectively near-zero for an ₹7,41,551 crore market-cap company. At P/E of 15.07, TCS is the most attractively valued name in this list on earnings multiples.

Infosys and HCL Tech: Solid ROCE at Reasonable Valuations

Infosys (NSE: INFY) reports 40% ROCE with PAT of ₹29,474 crore on revenues of ₹1,78,650 crore and a P/E of 14.48x — broadly in line with TCS multiples. HCL Technologies (NSE: HCLTECH) delivers 31% ROCE with PAT of ₹16,652 crore and a P/E of 18.76x. Both carry near-zero leverage (D/E 0.10 and 0.07 respectively), making them structurally low-risk.

Marico and Pidilite: Compounders with Mid-Range ROCE

Marico (NSE: MARICO) earns 47% ROCE on revenues of ₹13,611 crore with PAT of ₹1,813 crore and a PAT margin of 13.3%. Pidilite Industries (NSE: PIDILITIND) — India's dominant adhesives player — reports 31% ROCE with PAT of ₹2,471 crore on revenues of ₹14,601 crore. Pidilite's D/E of 0.04 is among the lowest in the large-cap universe. Both trade at premium multiples (63x and 66x P/E respectively) reflecting quality premia.

Key Takeaways: Quality at a Price

High ROCE names like Colgate, Nestle, and Page Industries invariably trade at elevated P/E ratios (40x–85x). The IT majors — TCS and Infosys — are the exception: similar capital efficiency at 15x earnings. Investors seeking ROCE-quality at fair valuation may find the IT majors more compelling on a pure valuation basis. FMCG compounders offer consistent earnings growth but require patience at current multiples.

SEBI Disclaimer: This is for informational purposes only and not investment advice. Please consult a SEBI-registered advisor before investing.
Apply this on DocStoX

Screen 6,000+ NSE & BSE stocks on these exact metrics, or ask DoXy, our AI analyst. Open the screener · More guides

Informational and educational purposes only, not investment advice. DocStoX is not a SEBI-registered advisor. Consult a SEBI-registered advisor before investing.